https://www.amavitaresearch.com/es 2026-04-30 weekly 0.90 https://www.amavitaresearch.com/es/patients 2026-04-30 weekly 0.81 https://www.amavitaresearch.com/es/sponsors 2026-04-30 weekly 0.81 https://www.amavitaresearch.com/es/about 2026-05-13 monthly 0.72 https://www.amavitaresearch.com/es/team 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/team/william-oneill 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/team/pedro-martinez-clark 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/team/hans-rutzen-lopez 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/team/yasnaya-cruz-santiago 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/team/orlando-ortega-izquierdo 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/team/nereisy-alonso 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/team/julio-martinez-clark 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/contact-patient 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/contact-sponsor 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/blog 2026-04-30 weekly 0.72 https://www.amavitaresearch.com/es/glossary 2026-04-30 monthly 0.54 https://www.amavitaresearch.com/es/trials 2026-04-30 weekly 0.81 https://www.amavitaresearch.com/es/trials/zenith-zilebesiran 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/trials/librexia-acs 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/trials/jk07-heart-failure 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/trials/iv-ferric-derisomaltose 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/trials/vs-041-hfpef 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/trials/golazo-great 2026-05-12 monthly 0.63 https://www.amavitaresearch.com/es/blog/what-is-a-cardiovascular-clinical-trial 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/blog/who-qualifies-cardiovascular-trial-miami 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/blog/what-is-tavr-transcatheter-aortic-valve-replacement 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/blog/peripheral-artery-disease-symptoms-diagnosis-treatment 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/blog/what-is-atherectomy 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/blog/how-first-in-human-cardiovascular-trials-are-conducted-safely 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/blog/clinical-trial-phases-explained 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/blog/what-to-expect-as-a-patient 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/careers 2026-04-30 monthly 0.54 https://www.amavitaresearch.com/es/investigators 2026-04-30 monthly 0.54 https://www.amavitaresearch.com/es/compare/amavita-vs-baptist-health 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/compare/amavita-vs-university-of-miami 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/compare/amavita-vs-flourish-research 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/compare/amavita-vs-academic-medical-center 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/compare/amavita-vs-mcrc 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/compare/amavita-vs-sfcri 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/compare/amavita-vs-altior 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/compare/specialist-site-vs-site-network 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/compare/dedicated-cv-asc-vs-hospital-based-research 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/compare/independent-site-vs-academic-medical-center 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/vs-cro-without-practice 2026-04-30 monthly 0.72 https://www.amavitaresearch.com/es/faq-sponsors 2026-05-12 monthly 0.72 https://www.amavitaresearch.com/es/faq-patients 2026-05-12 monthly 0.72 https://www.amavitaresearch.com/es/locations 2026-04-30 monthly 0.63 https://www.amavitaresearch.com/es/privacy 2026-04-30 yearly 0.27 https://www.amavitaresearch.com/es/cookies 2026-04-30 yearly 0.27 https://www.amavitaresearch.com/es/terms 2026-04-30 yearly 0.27 https://www.amavitaresearch.com/es/accessibility 2026-04-30 yearly 0.27 https://www.amavitaresearch.com/es/hipaa-notice 2026-04-30 yearly 0.27